-
Poster Presentation (SLAS 2024, 3-7 February, 2024 Boston, MA)
Deep characterization of binding kinetics for 210 kinase inhibitors against 80+ kinases
-
Poster Presentation (SLAS 2024, 3-7 February, 2024 Boston, MA)
The Development of a Novel Mobility Shift Analysis System for Kinase Small Molecule Drug Discovery using the SCIEX BioPhase 8800
-
Poster Presentation (Next Generation Kinase Inhibitors Summit, 29-31 March, 2022 Boston, MA)
NanoBRET™ Intracellular Kinome-Wide Profiling of BTK inhibitors and
Mechanism of Action Analysis of Selected Compounds.
-
Poster Presentation (SLAS2022)
NanoBRET™ Intracellular Kinome-Wide Profiling of BTK inhibitors and
Mechanism of Action Analysis of Selected Compounds.
-
Poster Presentation (Drug Discovery Digital ELRIG 2020)
Title: Kinetic Monitoring of Compound Dissociation from Wild-type and Mutant Kinase in Living Cells with NanoBRET™
-
Promega Presentation (SLAS2020) Broad Kinome Selectivity and Residence Time Analysis in Live Cells with NanoBRET
-
-
Poster Presentation (2019 ELRIG in Liverpool)
Title：New Method to Determine Drug-Target Residence Time of Kinase Inhibitors in Living Cells.
-
Poster Presentation: A New Method to Determine Drug-Target Residence Time of Kinase Inhibitors in Living Cells (AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics, 2019)
-
Poster Presentation (3rd Reverse-Phase Protein Array Global Workshop)
Title：DIFFERENCES IN RESPONSE TO TYROSINE KINASE INHIBITORS BETWEEN K-RAS-MUTANT NON SMALL CELL LUNG CANCER AND COLORECTAL CANCER CELL LINES ELUCIDATED BY THE RPPA SPECIFIC TO PHOSPHO-PROTEOMICS ANALYSIS.
-
Poster Presentation (3rd Reverse-Phase Protein Array Global Workshop)
Title：EFFECTS OF PHOSPHATIDYLINOSITOL-3-KINASE (PI3K) INHIBITOR ON CELLULAR SIGNAL NETWORKS IN GLIOMA CELL LINES.
-
Poster Presentation (2013 AACR Annual Meeting)
Title: Pathway oriented phospho-proteomics analysis with reverse phase protein array
(RPPA) technology in cell growth and cancer therapy
-
Poster Presentation (2013 AACR Annual Meeting)
Title: Highly sensitive kinase assays combining Carna Biosciences QSS Assist ELISA reagents with the Meso Scale Discovery MULTI-ARRAY platform
-
Poster Presentation (2011)
Title: A novel binding assay to identify inhibitors that bind to inactive forms of Bruton’s tyrosine kinase based on fluorescence resonance energy transfer
-
Poster Presentation (2011)
Title: The design and synthesis of a novel fluorogenic probe targeting inactive forms of Bruton's tyrosine kinase for high throughput binding assay
-
Poster Presentation (SBS, 2011)
Title: Site Specific Biotinylated Protein Kinase is Easy-to-Use Solution in the SPR Technology for Kinase Inhibitor Evaluation
-
Poster Presentation (Drug Discovery TARGET & TOOL, 2011)
Title: Site Specific Biotinylated Protein Kinase is Easy-to-Use Solution in the SPR Technology for Kinase Inhibitor Evaluation
-
Poster Presentation (Next-Gen Kinase Inhibitors, 2010)
Title: Activity and Affinity- based assay of FMS tyrosine kinase: the impact of kinase phosphorylation state on the activities of various kinase inhibitory compounds
-
Poster Presentation (SBS, 2010)
Title: Activity-based kinase selectivity profiling of clinically relevant tyrosine kinase inhibitors using QuickScout™
-
Poster Presentation (SBS, 2007)
Title: Comprehensive Protein Kinase Profiling Panel for Selective Inhibitor Screening provided by Carna Biosciences ”The Kinase company”
-
Poster Presentation (DDT, 2005)
Title: Entire human tyrosine kinase profiling panel will help to develop the specific kinase inhibitor
